Demethylbellidifolin preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level

Journal of Ethnopharmacology

Volumn 93, Issue 2-3, 2004, Pages 295-306

  Jiang, De Jian ^a   Jiang, Jun Lin ^a   Zhu, Hui Qing ^a   Tan, Gui Shan ^a   Liu, Shao Qian ^a   Xu, Kang Ping ^a   Li, Yuan Jian ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Asymmetric dimethylarginine; Demethylbellidifolin; Dimethylarginine dimethylaminohydrolase; Endothelium; Lipid peroxidation; Low density lipoprotein

Indexed keywords

COPPER ION; DIMETHYLARGININASE; LACTATE DEHYDROGENASE; LOW DENSITY LIPOPROTEIN; LYSOPHOSPHATIDYLCHOLINE; MALONALDEHYDE; NITRIC OXIDE SYNTHASE INHIBITOR; NORBELLIDIFOLIN; PLANT EXTRACT; UNCLASSIFIED DRUG;

ARTICLE; ATTENUATION; CELL DAMAGE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG INHIBITION; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IN VIVO STUDY; LIPID PEROXIDATION; OXIDATION; REDUCTION;

ANIMALS; ANTIOXIDANTS; AORTA; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; MALE; NITRIC OXIDE SYNTHASE; PHYTOTHERAPY; PICRATES; PLANT EXTRACTS; RATS; RATS, SPRAGUE-DAWLEY; SWERTIA; VASODILATION; XANTHENES;

EID: 3042724189     PISSN: 03788741     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jep.2004.03.055     Document Type: Article

References (42)

1. Aviram M., Rosenblat M. Macrophage mediated oxidation of extracellular low-density lipoprotein requires an initial binding of the lipoprotein to its receptor. Journal of Lipid Research. 35:1994;385-398
2. Berliner J.A., Heinecke J.W. The role of oxidized lipoproteins in atherosclerosis. Free Radical Biology & Medicine. 20:1996;707-727
3. Böger R.H., Bode-Böger S.M., Szuba A., Tsao P.S., Chan J.R., Tangphao O., Blaschke T.F., Cooke J.P. Asymmetric dimethylarginine: a novel risk factor for endothelial dysfunction: its role in hypercholesterolemia. Circulation. 98:1998;1842-1847
4. Böger R.H., Bode-Böger S.M., Sydow K., Heistad D.D., Lentz S.R. Plasma concentration of asymmetric dimethylarginine, an endogenous inhibitor of nitric oxide synthase is elevated in monkeys with hyperhomocyst(e)inemia or hypercholesterolemia. Arteriosclerosis, Thrombosis, and Vascular Biology. 20:2000a;1557-1564
5. Böger R.H., Sydow K., Borlak J., Thum T., Lenzen H., Schubert B., Tsikas D., Bode-Böger S.M. LDL cholesterol upregulates synthesis of asymmetrical dimethylarginine in human endothelial cells: involvement of S-adenosylme-thionine-dependent methyltransferases. Circulation Research. 87:2000b;99-105
6. Bode-Böger S.M., Böger R.H., Kienke S., Junker W., Frölich J.C. Elevated L-arginine/dimethylarginie ratio contributes to enhanced systemic NO production by dietary L-arginine in hypercholesterolemic rabbits. Biochemical and Biophysical Research Communications. 219:1996;598-603
7. Calara F., Dimayuga P., Niemann A., Thyberg J., Diczfalusy U., Witztum J.L., Palinski W., Shah P.K., Cercek B., Nilsson J., Regnstrom J. An animal model to study local oxidation of LDL and its biological effects in the arterial wall. Arteriosclerosis, Thrombosis, and Vascular Biology. 18:1998;884-893
8. Chang C.H., Lin C.C., Hattori M., Namba T. Effects on anti-lipid peroxidation of Cudrania cochinchinensis var. gerontogea. Journal of Ethnopharmacology. 44:1994;79-85
9. Chen B.M., Xia L.W., Zhao R.Q. Determination of NG,NG-dimethylarginine in human plasma by high-performance liquid chromatography. Biomedical Applications. 692:1997;467-471
10. Cooke J.P. Does ADMA cause endothelial dysfunction? Arteriosclerosis, Thrombosis, and Vascular Biology. 20:2000;2032-2037
11. Feng Q., Lu X., Jones D.L., Shen J., Arnold J.M. Increased inducible nitric oxide synthase expression contributes to myocardial dysfunction and higher mortality after myocardial infarction in mice. Circulation. 104:2001;700-704
12. Gonda R., Takeda T., Akiyama T. Studies on the constituents of Anaxagorea luzonensis A. GRAY. Chemical & Pharmaceutical Bulletin. 48:2000;1219-1222
13. Havel R.J., Eder H.A., Bragdon J.H. The distribution and chemical composition of ultra-centrifugally separated lipoproteins in human serum. The Journal of Clinical Investigation. 34:1955;1345-1353
14. He Q.H., Xu S.B., Peng B. Mechanism of Canscora lucidissima xanthones against arrhythmia induced by myocardial ischemia reperfusion in rats. Zhongguo Zhong Yao Za Zhi. 23:1998;556-557
15. Heinecke J.W., Rosen H., Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. The Journal of Clinical Investigation. 74:1984;1980-1984
16. Hussain T., Leigh J.H., Mustafa S.J. Regulation of adenosine receptor function by theophylline in rat aorta. Journal of Cardiovascular Pharmacology. 24:1994;95-99
17. Ito A., Tsao P.S., Adimoolam S., Kimoto M., Ogawa T., Cooke J.P. Novel mechanism for endothelial dysfunction: dysregulation of dimethylarginine dimethylaminohydrolase. Circulation. 99:1999;3092-3095
18. Jiang D.J., Tan G.S., Zhou Z.H., Xu K.P., Ye F., Li Y.J. Protective effects of demethylbellidifolin on myocardial ischemia-reperfusion injury in rats. Planta Medica. 68:2002;710-713
19. Jiang J.L., Li N.S., Li Y.J., Deng H.W. Probucol preserves endothelial function by reduction of the endogenous nitric oxide synthase inhibitor level. British Journal of Pharmacology. 135:2002;1175-1182
20. Kimoto M., Whitley G.S., Tsuji H., Ogawa T. Detection of NG, NG-dimethylarginine dimethylaminohydrolase in human tissues using a monoclonal anti-body. Journal of Biochemistry. 117:1995;237-238
21. Kurose I., Wolf R., Grisham M.B., Granger D.N. Effects of an endogenous inhibitor of nitric oxide synthesis on postcapillary venules. The American Journal of Physiology. 268:1995;H2224-H2231
22. Lebeau J., Furman C., Bernier J.L., Duriez P., Teissier E., Cotelle N. Anti-oxidant properties of di-tert-butylhydroxylated flavonoids. Free Radical Biolology & Medicine. 29:2000;900-912
23. Li Y.J., Li Y.J., Peng C.F., Li N.S., You J.M., Deng H.W. Calcitonin gene-related peptide protects against endothelial cell damage due to oxidized low-density liporotein. Medical Science Research. 23:1995;253-254
24. Libby P. Inflammation in atherosclerosis. Nature. 420:2002;868-874
25. Librowski T., Czarnecki R., Jastrzebska M. Chiral 2-amino-1-butanol xanthone derivatives as potential anti-arrhythmic and hypotensive agents. Acta Polish Pharmacology. 56:1999;87-89
26. Lin K.Y., Ito A., Asagami T., Tsao P.S., Adimoolam S., Kimoto M., Tsuji H., Reaven G.M., Cooke J.P. Impaired nitric oxide synthase pathway in diabetes mellitus: role of asymmetric dimethylarginine and dimethylarginine dimethylaminohydrolase. Circulation. 106:2002;987-992
27. Lowry O.H., Rosebroough N.J., Farr A.L., Randall R.J. Protein measurement with the folin phenol reagent. Journal of Biological Chemistry. 193:1951;265
28. Madan B., Singh I., Kumar A., Prasad A.K., Raj H.G., Parmar V.S., Ghosh B. Xanthones as inhibitors of microsomal lipid peroxidation and TNF-alpha induced ICAM-1 expression on human umbilical vein endothelial cells (HUVECs). Bioorganic & Medicinal Chemistry. 10:2002;3431-3436
29. Mahabusarakam W., Proudfoot J., Taylor W., Croft K. Inhibition of lipoprotein oxidation by prenylatted xanthones derived from mangostin. Free Radical Research. 33:2000;643-659
30. Minami H., Takahashi E., Fukuyama Y., Kodama M., Yoshizawa T., Nakagawa K. Novel xanthones with superoxide scavenging activity from Garcinia subelliptica. Chemical & Pharmaceutical Bulletin. 43:1995;347-349
31. Murugandndan S., Gupta S., Kataria M., Lal J., Gupta P.K. Mangiferin protects the streptozotocin-induced oxidative damage to cardiac and renal tissues in rats. Toxicology. 176:2002;165-173
32. Ohkawa H., Ohishi N., Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry. 95:1979;351-358
33. Peres V., Nagem T.J., De oliveira F.F. Tetraoxygenated naturally occurring xanthones. Phytochemistry. 55:2000;683-710
34. Steinberg D. Low density lipoprotein oxidation and its pathobiological significance. The Journal of Biological Chemistry. 272:1997;20963-20966
35. Stuhlinger M.C., Tsao P.S., Her J.H., Kimoto M., Balint R.F., Cooke J.P. Homocysteine impairs the nitric oxide synthase pathway: role of asymmetric dimethylarginine. Circulation. 104:2001;2569-2575
36. Stuhlinger M.C., Tsao P.S., Kimoto M., Cooke J.P. Homocysteine induced accumulation of asymmetric dimethylarginine: role of DDAH and effect of anti-oxidants. Circulation. 102:2000;II-177
37. Surdacki A., Nowicki M., Sandmann J., Tsikas D., Boeger R.H., Bode-Boeger S.M., Kruszelnicka-Kwiatkowska O., Kokot F., Dubiel J.S., Froelich J.C. Reduced urinary excretion of nitric oxide metabolites and increased plasma levels of asymmetric dimethylarginine in men with essential hypertension. Journal of Cardiovascular Pharmacology. 33:1999;652-658
38. Usui M., Matsuoka H., Miyazaki H., Ueda S., Okuda S., Imaizumi T. Increased endogenous nitric oxide synthase inhibitor in patient with congestive heart failure. Life Sciences. 62:1998;2425-2430
39. Vallance P., Leone A., Calver A., Collier J., Moncada S. Accumulation of an endogenous inhibitor of NO synthesis in chronic renal failure. Lancet. 339:1992;572-575
40. Witztum J.L., Steinberg D. Modification of low-density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low-density lipoprotein phospholipids. Proceedings of the National Academy of Sciences of the United States of America. 81:1984;3883-3887
41. Xiong Y., Li Y.J., Yu X.J., Liu G.Z., Li N.S. Endogenous inhibitor of nitric oxide synthesis and lipid peroxidation in hyperlipidemic rabbits. Acta Pharmacologica Sinica. 17:1996;149-152
42. Yu X.J., Li Y.J., Xiong Y. Increase of an endogenous inhibitor of nitric oxide synthesis in serum of high cholesterol fed rabbits. Life Sciences. 54:1994;753-758